InsidersTradesSigma
Discover the detailed record of transactions filed by Groman Dan, Chief Technology Officer. Director active across 1 company, notably Enfusion, Inc.. Aggregated, 1 filings have been recorded. History available since 15 June 2022. The latest transaction was disclosed on 15 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Dan Groman is the Chief Technology Officer at Enfusion, Inc. He is responsible for the company's technological direction, overseeing the development of innovative solutions. His role is crucial in ensuring that Enfusion's products meet market needs and customer requirements. With his expertise, he contributes to the company's technological strategy and innovation.